Clinical characteristics and prognostic value of the <i>KRAS G12C</i> mutation in Chinese non-small cell lung cancer patients.

导出 LinkOut

翻译打印收藏纠错

作者： Si-Yang,Liu ^[1] ; Hao,Sun ^[1] ; Jia-Ying,Zhou ^[1] ; Guang-Ling,Jie ^[1] ; Zhi,Xie ^[1] ; Yang,Shao ^[2] ; Xian,Zhang ^[2] ; Jun-Yi,Ye ^[3] ; Chun-Xiang,Chen ^[3] ; Xu-Chao,Zhang ^[1] ; Qing,Zhou ^[1] ; Jin-Ji,Yang ^[1] ; Yi-Long,Wu ^[1]

作者单位： Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, 106 Zhongshan Er Road, Guangzhou, 510080 China. ^[1] Nanjing Geneseeq Technology Inc., Nanjing, 210032 China. ^[2] Burning Rock Biotech, Guangzhou, 510000 China. ^[3]

关键词 Chinese patients KRAS G12C mutation KRAS mutation Non-small cell lung cancer Prognosis

DOI 10.1186/s40364-020-00199-z

PMID 32607238

发布时间 2022-04-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Biomarker research

2020年8卷

22页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Clinical characteristics and prognostic value of the <i>KRAS G12C</i> mutation in Chinese non-small cell lung cancer patients.

Biomarker research

相似文献

Biomarker research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Clinical characteristics and prognostic value of the <i>KRAS G12C</i> mutation in Chinese non-small cell lung cancer patients.

Biomarker research

相似文献

Biomarker research

相关期刊

检索历史清除